Edwards Receiveds FDA Approval for Transcatheter Heart Valve Trial

Edwards Receiveds FDA Approval for Transcatheter Heart Valve Trial: "Edwards Lifesciences Corporation (NYSE: EW - News), the world leader in the science of heart valves, announced today that it has received conditional approval from the U.S. Food and Drug Administration (FDA) to initiate a pivotal clinical trial of its Edwards SAPIEN transcatheter aortic heart valve technology. The PARTNER (Placement of AoRTic traNscathetER valves) trial will evaluate the SAPIEN valve in patients who are considered high risk for conventional open-heart valve surgery."